Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Application of Multimodal Artificial Intelligence Systems in Prostate Cancer Diagnosis and Prognosis Analysis

NCT06589154 is registered in ClinicalTrials.gov with Shanghai Changzheng Hospital as lead sponsor.

NCT NCT06589154
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06589154 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Application of Multimodal Artificial Intelligence Systems in Prostate Cancer Diagnosis and Prognosis Analysis
Lead sponsor
Shanghai Changzheng Hospital
Phase
Observational
Overall status
Completed
Start date
October 10, 2024
Completion date
July 30, 2025
Enrollment
1,651 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

benign prostatic hyperplasia, healthy people, prostate cancer